These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4892942)

  • 41. Effect of bunaphtine on right atrial repolarisation in man.
    Fenici R; Marchei M; Bellocci F; Zecchi P
    Br Heart J; 1977 Jul; 39(7):787-94. PubMed ID: 328029
    [No Abstract]   [Full Text] [Related]  

  • 42. [French language seminar in cardiology. Contribution of pharmacology to the study and treatment of arrhythmia. Introduction].
    Chiche P
    Acta Cardiol; 1977; Suppl 22():9-12. PubMed ID: 301693
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His].
    Scibilia G; Bonatti V; Pavarani A; Tagliavini S; Botti G
    Cardiol Prat; 1973; 24(1):79-84. PubMed ID: 4575451
    [No Abstract]   [Full Text] [Related]  

  • 44. Antihypertensive compounds as antiarrhythmic agents: focus on beta-blocking drugs in ventricular arrhythmias.
    Singh BN; Nademanee K
    Am Heart J; 1987 Oct; 114(4 Pt 2):1040-50. PubMed ID: 2444089
    [No Abstract]   [Full Text] [Related]  

  • 45. [Injectable diphenylhydantoin in cardiology. Experimental study].
    Quiret JC; Bens JL; Duboisset M; Lesbre P; Bernasconi P
    Arch Mal Coeur Vaiss; 1974 Jan; 67(1):87-96. PubMed ID: 4211204
    [No Abstract]   [Full Text] [Related]  

  • 46. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Electrophysiology of cardiac arrhythmias].
    Sumbera J; Bravený P
    Cesk Fysiol; 1977; 26(6):505-39. PubMed ID: 342125
    [No Abstract]   [Full Text] [Related]  

  • 48. The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice.
    Colussi C; Berni R; Rosati J; Straino S; Vitale S; Spallotta F; Baruffi S; Bocchi L; Delucchi F; Rossi S; Savi M; Rotili D; Quaini F; Macchi E; Stilli D; Musso E; Mai A; Gaetano C; Capogrossi MC
    Cardiovasc Res; 2010 Jul; 87(1):73-82. PubMed ID: 20164117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrophysiology and pharmacology of aprindine, encainide, and propafenone.
    Zipes DP; Prystowsky EN; Heger JJ
    Ann N Y Acad Sci; 1984; 432():201-9. PubMed ID: 6441495
    [No Abstract]   [Full Text] [Related]  

  • 50. [Mechanism of action of antiarrhythmic agents].
    Méndez R
    Arch Inst Cardiol Mex; 1977; 47(2):223-32. PubMed ID: 901057
    [No Abstract]   [Full Text] [Related]  

  • 51. [Ventricular repolarization].
    Funck-Brentano C
    Arch Mal Coeur Vaiss; 1992 Jul; 85(7):1015-21. PubMed ID: 1449334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrophysiology and pharmacology of cardiac arrhythmias. III. The causes and treatment of cardiac arrhythmias. Part A.
    Hoffman BF; Rosen MR; Wit AL
    Am Heart J; 1975 Jan; 89(1):115-22. PubMed ID: 1109541
    [No Abstract]   [Full Text] [Related]  

  • 53. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 54. Modulation of spiral wave reentry by K(+) channel blockade.
    Honjo H; Yamazaki M; Kamiya K; Kodama I
    Circ J; 2007; 71 Suppl A():A26-31. PubMed ID: 17587736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental and clinical pharmacology of cardiac arrhythmias.
    Haas HH
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):173-7. PubMed ID: 4254276
    [No Abstract]   [Full Text] [Related]  

  • 56. Postrepolarization refractoriness: a mechanism in need for a molecule?
    Kirchhof P; Fabritz L
    Heart Rhythm; 2012 Jun; 9(6):983-4. PubMed ID: 22334152
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect on intracellular atrial potentials of bretylium in relation to its local anaesthetic potency.
    Papp JG; Williams EM
    Br J Pharmacol; 1969 Feb; 35(2):P352-3. PubMed ID: 5774055
    [No Abstract]   [Full Text] [Related]  

  • 58. Modification of the electrophysiologic matrix by antiarrhythmic drugs.
    Hoffman BF
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):28B-30B. PubMed ID: 3923078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents.
    Perry RS; Illsley SS
    Am J Hosp Pharm; 1986 Apr; 43(4):957-74. PubMed ID: 2871752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.